|
Model Number 1VTEC30 |
Device Problem
Contamination (1120)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 05/06/2022 |
Event Type
malfunction
|
Event Description
|
It was reported that white particles were observed over the lens when it was injected from the cartridge into the patient's eye.The surgeon washed the lens while doing ophthalmic viscoelastic device (ovd) removal, but particles were remained over it.The surgeon noticed that the particles were inside the cartridge and that they did not have a normal luster.It was noted that the cartridge was quite opaque and that with naked eyes particles were not visible at the tip of cartridge.It was indicated that a non-johnson and johnson sodium hyaluronate ovd and balanced salt solution (bss) for irrigation was used.There was no delay in treatment and no medical or surgical interventions required.The lens remains implanted in the eye and reportedly, the patient is good post-operation and can see clearly.There was no patient injury reported.No further information was provided.No further information was provided.
|
|
Manufacturer Narrative
|
Unknown/not provided, information was asked but it was not provided.If implanted; give date: n/a (not applicable).The cartridge is not an implantable device.If explanted; give date: n/a (not applicable).The cartridge is not an implantable device; therefore; not explanted.Concomitant medical products: intraocular lens, model zfr00v -23.5, sn (b)(6) sodium hyaluronate ( cohevisc brand); clearsol bss.Initial reporter telephone number: (b)(6).The device has not returned for evaluation.Therefore, a failure analysis of the complaint device cannot be completed.A review of the device lot history record, complaint trending, and risk documentation for this device will be performed.Upon completion of the review, if there is any further relevant information a supplemental medwatch will be filed.Attempts have been made to obtain the missing information; however, to date, the information has not been received.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
|
|
Manufacturer Narrative
|
Section d9: device available for evaluation: yes.Date returned to manufacturer: june 1, 2022.Section h3: device returned to manufacturer: yes.Device evaluation: visual inspection was performed under magnification.The complaint lens presented with particles and debris inside the cartridge body and tip.The cartridge was forwarded to eag laboratories for ftir analysis.Ftir results were compared the manufacturing site component database and no matches exceeded the threshold of 0.9 comparison threshold.The closest comparison match was 0.46 and was 52846-007lens paper 8x12 inches.Eag compared the results to their own materials database and reported that the material appeared to contain methyl cellulose and a salt species similar to sodium hyaluronate.Edx was also performed by eag laboratories and also supported the conclusion of the material containing sodium hyaluronate.Subject matter expert (sme) reviewed the product evaluation and eag results.The sme suggested that the material could be residual non-j&j ovd, which is supported by the information in the complaint.Conclusion: based on complaint investigation results, there is no indication of a product malfunction or product quality deficiency.No nonconformity report, documentation or labeling changes, and escalations are required.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
|
|
Search Alerts/Recalls
|
|
|